You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKesson
Medtronic
Moodys
Merck

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

HYDRALAZINE HYDROCHLORIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Hydralazine Hydrochloride, and when can generic versions of Hydralazine Hydrochloride launch?

Hydralazine Hydrochloride is a drug marketed by Abraxis Pharm, Akorn, Am Regent, Fresenius Kabi Usa, Mylan Institutional, Navinta Llc, Smith And Nephew, Solopak, Teva Parenteral, Xgen Pharms, Actavis Elizabeth, Actavis Grp Ptc, Alkem Labs Ltd, Anda Repository, Ascot, Cadila Pharms Ltd, Chartwell Rx, Glenmark Pharms Ltd, Halsey, Heritage Pharms Inc, Hetero Labs Ltd Iii, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Par Pharm, Pliva, Purepac Pharm, Quantum Pharmics, Sciegen Pharms Inc, Strides Pharma, Superpharm, Upsher Smith Labs, Usl Pharma, Vangard, Vitarine, Watson Labs, West Ward, Solvay, and Ivax Pharms. and is included in ninety-two NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE
Drug Prices for HYDRALAZINE HYDROCHLORIDE

See drug prices for HYDRALAZINE HYDROCHLORIDE

Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Brigham and Women's HospitalPhase 2
University of MichiganPhase 2
Medical College of WisconsinN/A

See all HYDRALAZINE HYDROCHLORIDE clinical trials

Pharmacology for HYDRALAZINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for HYDRALAZINE HYDROCHLORIDE

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 086961-002 Approved Prior to Jan 1, 1982 AA RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 085088-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Halsey HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 089178-001 Jan 15, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Rx HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088848-001 Feb 26, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Sciegen Pharms Inc HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 205236-002 May 26, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
West Ward HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088241-001 May 27, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKesson
Medtronic
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.